+$0.81 (+0.86%) Today
+$0.11 (+0.12%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Merck and other ETFs, options, and stocks.

About MRK

Merck & Co., Inc. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.

Robert M. Davis
Kenilworth, New Jersey

MRK Key Statistics

Market cap
Price-Earnings ratio
Dividend yield
Average volume
High today
Low today
Open price
52 Week high
52 Week low

MRK News


Merck Gets EU Approval of Expanded Keytruda Use in Breast Cancer - MarketWatch

By Colin Kellaher Merck & Co. on Tuesday said the European Commission approved the expanded use of its blockbuster cancer drug Keytruda for certain breast-canc
Simply Wall StMay 21

Merck stock performs better than its underlying earnings growth over last five years

When you buy and hold a stock for the long term, you definitely want it to provide a positive return. Furthermore, you'd generally like to see the share price r
BenzingaMay 20

CHMP Supports Approval Of Merck's Keytruda As Adjuvant In Post Surgery Melanoma Setting

European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending Merck & Co Inc (NYSE: MRK) Keytrud

MRK Earnings

Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
— per share
Available Jul 28, Pre-Market

More MRK News

MarketWatchMay 20

Merck Gets CHMP Backing for Expanded Keytruda Use in Melanoma >MRK - MarketWatch

By Colin Kellaher Merck & Co. on Friday said the European Medicines Agency's Committee for Medicinal Products for Human Use recommended expanded approval of it
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure